Five years since the UK government was called on to take action to reduce deaths and injuries associated […]

Meet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards

Agreement will utilise RetinAI’s IT solutions and artificial intelligence tools to support projects in ophthalmology

Vaccine candidate previously scored fast-track and breakthrough therapy designations

ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma

‘Encouraging’ data for investigational candidates across a range of blood cancers

Updated Date: Tue, 01 Dec 2020 00:00:00 EST

FDA dings Bristol Myers’ CAR-T plant. Will it hurt liso-cel’s approval prospects—and investors’ CVR value? aliu Tue, 12/08/2020 […]

Klick Health annual holiday video debuts in animation, reinforces kindness message bbulik Tue, 12/08/2020 – 10:01

U.S. agency behind Kodak’s beefy drug manufacturing loan played by the books, investigation finds: report fkansteiner Tue, 12/08/2020 […]